The pathology of myocardial infarction in the pre- and post-interventional era

Heart

Volumn 92, Issue 11, 2006, Pages 1552-1556

  Pasotti, M ^a   Prati, F ^b   Arbustini, Eloisa ^a,c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Cardiovascular Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; TRIPHENYLTETRAZOLIUM; TROPONIN;

BLEEDING; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CONFERENCE PAPER; CORONARY ARTERY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; FALSE ANEURYSM; GASTROINTESTINAL HEMORRHAGE; HEART ANEURYSM; HEART ARRHYTHMIA; HEART INFARCTION; HEART RUPTURE; HUMAN; LUNG EDEMA; MITRAL VALVE REGURGITATION; PERICARDITIS; PRIORITY JOURNAL; STAINING; SUDDEN DEATH; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ARRHYTHMIA; CORONARY VESSELS; HEART ANEURYSM; HEART RUPTURE, POST-INFARCTION; HEMORRHAGE; HUMANS; LUNG DISEASES; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL INFARCTION; PERICARDITIS; PULMONARY EDEMA; SHOCK, CARDIOGENIC; THROMBOLYTIC THERAPY;

EID: 33750347281     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.086934     Document Type: Conference Paper

References (32)

1. American College of Cardiology, American Heart Association. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2002;106:1893-900.
2. Antman EM, Anbe DT, Armstrong PW, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation 2004;110:e82-292.
3. Polanczyk CA, Schneid S, Imhof BV, et al. Impact of redefining acute myocardial infarction on incidence, management and reimbursement rate of acute coronary syndromes. Int J Cardiol 2006;107:180-7.
4. Mahajan N, Mehta Y, Rose M, et al. Elevated troponin level is not synonymous with myocardial infarction. Int J Cardiol 2005 Nov 9; [Epub ahead of print].
5. Robbins SL, Cotran RS. Pathologic basis of disease. Elsevier Saunders, 2005.
6. Al-Habori M. The potential adverse effects of habitual use of Catha edulis (khat). Expert Opin Drug Saf 2005;4:1145-54.
7. Kounis NG, Kouni SN, Koutsojannis CM. Myocardial infarction after aspirin treatment, and Kounis syndrome. J R Soc Med 2005;98:21-3.
8. Yetkin E, Aksoy Y, Turhan H. Coronary vasospasm due to hypercholinergic crisis: an example of normal coronary arteriogram and myocardial infarction. Int J Cardiol 2005 Nov 27; [Epub ahead of print].
9. Rossi L, Dander B, Nidasio GP, et al. Myocardial bridges and ischemic heart disease. Eur Heart J 1980;1:239-45.
10. De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004;109:1223-5.
11. Salinas-Madrigal L, Osornio-Vargas A, Medrano G. Experimental reevaluation of myocardial ondulations in the early histological diagnosis of myocardial infarct. Arch Inst Cardiol Mex 1979;49:908-18.
12. Arbustini E, Dal Bello B, Morbini P, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999;82:269-72.
13. Burke AP, Farb A, Malcom GT, et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998;97:2110-16.
14. Arbustini E, Grasso M, Diegoli M, et al. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical and biochemical study. Am J Cardiol 1991;68:36B-50B.
15. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-62.
16. Reffelmann T, Kloner RA. The no-reflow phenomenon: basic science and clinical correlates. Heart 2002;87:162-8.
17. Prati F, Pawlowski T, Gil R, et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study. Circulation 2003;107:2320-5.
18. De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005;293:1759-65.
19. Stone GW, Webb J, Cox DA, et al for the Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005;293:1063-72.
20. Pena-Gil C, Figueras J, Soler-Soler J. Acute cardiogenic pulmonary edema. Relevance of multivessel disease, conduction abnormalities and silent ischemia. Int J Cardiol 2005;103:59-66.
21. Nakamura F, Minamino T, Higashino Y, et al. Cardiac free wall rupture in acute myocardial infarction: ameliorative effect of coronary reperfusion. Clin Cardiol 1992;15:244-50.
22. Pollak H, Nobis H, Miczoch J. Frequency of left ventricular free wall rupture complicating acute myocardial infarction since the advent of thrombolysis. Am J Cardiol 1994;74:184-6.
23. Crenshow BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32.
24. Tikiz H, Balbay Y, Atak R, et al. The effect of thrombolytic therapy on left ventricular aneurysm formation in acute myocardial infarction: relationship to successful reperfusion and vessel patency. Clin Cardiol 2001;24:656-62.
25. Neven KG, Crijns HJ, Cheriex EC. Late left ventricular pseudoaneurysm formation following subacute myocardial infarction. Int J Cardiol 2005;98:165-7.
26. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev 1999;79:917-1017.
27. Perron AD, Sweeney T. Arrhythmic complications of acute coronary syndromes. Emerg Med Clin North Am 2005;23:1065-82.
28. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003;107:2998-3002.
29. Shahar A, Hod H, Barabash GM, et al. Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. Cardiology 1994;85:255-8.
30. Razakjr OA, Tan HC, Yip WL, et al. Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention. J Interv Cardiol 2005;18:33-7.
31. Ali A, Hashem M, Rosman HS, et al. Use of platelet glycoprotein IIb/IIIa inhibitors and spontaneous pulmonary hemorrhage. J Invasive Cardiol 2003;15:189-90.
32. Kereiakes DJ, Lincoff AM, Anderson KM, et al for the EPIC Investigators, EPILOG Investigators, and EPISTENT Investigators. Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile. Am J Cardiol 2002;90:628-30.